CAS Investment Partners Reduces Stake in Cardlytics Amid Financial Challenges

CAS Investment Partners, a Connecticut-based firm, reduced its stake in Cardlytics Inc by 415,855 shares, a 7.41% decrease, while maintaining a significant position of 9.80% in its portfolio. The firm's investment strategy focuses on consumer cyclical and financial services sectors. Cardlytics Inc operates an advertising platform within financial institutions' digital channels and generates revenue through its Cardlytics and Bridg platforms. The company faces financial challenges with a low Balance Sheet Rank and negative Return on Equity and Return on Assets. The stock is considered a "Possible Value Trap" with a GF Value of $3.45 and a year-to-date price decline of 72.39%.